Gillian C. Ivers-read, See Remarks at Clovis Oncology, Inc. (CLVS), sold 598 shares at $7.03 ($4K) on 2020-06-03, disclosed to the SEC on 2020-06-05.
Seasonal sale ($4k) by See Remarks — this insider has traded CLVS in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.03 | 285 | $2K | 47.7% |
| 2 | $7.03 | 313 | $2K | 52.3% |
| Total | $7.03 avg | 598 | $4K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $6K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $1K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $7K | — | Filing → |